Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.95), $0.06 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
• ON Semiconductor (ON) call put ratio 1 call to 1.5 puts after acquiring Synaptics (SYNA)
• John Bolton pleads guilty to retaining national defense data